Key references: Women's health advice in multiple sclerosis

  • Alroughani R, Altintas A, Jumah M, Sahraian M, Alsharoqi I, AlTahan A, et al. Pregnancy and the use of disease-modifying therapies in patients with multiple sclerosis: benefits versus risks. Mult Scler Int 2016;2016:1034912. https://www.ncbi.nlm.nih.gov/pubmed/28078140
  • Bove R, White CC, Fitzgerald KC, Chitnis T, Chibnik L, Ascherio A, et al. Hormone therapy use and physical quality of life in postmenopausal women with multiple sclerosis. Neurology 2016;87(14):1457–63. https://www.ncbi.nlm.nih.gov/pubmed/27605175
  • Houtchens MK, Zapata LB, Curtis KM, Whiteman MK. Contraception for women with multiple sclerosis: Guidance for healthcare providers. Mult Scler 2017;23(6):757–64. https://www.ncbi.nlm.nih.gov/pubmed/28338393
  • Thone J, Thiel S, Gold R, Hellwig K. Treatment of multiple sclerosis during pregnancy - safety considerations. Expert Opin Drug Saf 2017;16(5):523–34. https://www.ncbi.nlm.nih.gov/pubmed/28333552